Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

Brian Tyree Henry delivers an excellent performance in Dope Thief, a Philly-based crime show. Stealing drugs and money does ...

Discover UroGen Pharma’s promising 2024 earnings call insights, with FDA progress on UGN-102 targeting $1B potential, robust pipeline updates & ...

It’s been just six months since Zevra Therapeutics scored an FD | Niemann-Pick disease type C therapy Miplyffa became ...

RBC Capital keeps a Buy rating and $82 price target on Cytokinetics (CYTK), saying the firm remains bullish on the stock following the ...

The FDA has started a priority review of Insmed's brensocatib ... the walls of the airways become thickened and damaged as a result of a cycle of inflammation and infections.

Darko, 28, has decided to end his life through euthanasia rather than continue living with bipolar disorder. He launched 'The ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

Incorporating dynamic pricing into cost-effectiveness analysis could offer significant benefits for equity in health care.

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, ...

Mehmet Oz, MD, President Donald Trump's pick for CMS administrator, sat through three hours of questioning March 14 from the Senate Finance Committee.